NCT00964561 - Ph1 Study of Valortim and Ciprofloxacin in Humans | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

July 31, 2010

Conditions

Anthrax

Interventions

DRUG

Ciprofloxacin and Valortim

Days 1-3 400mg IV Ciprofloxacin BID over 60 minutes. Day 4 20mg/kg Valortim IV over 60 minutes.

DRUG

Placebo Antibiotic and Valortim

Days 1-3 20mg/kg IV Normal Saline BID over 60 minutes. Day 4 20mg/kg Valortim IV over 60 minutes.

OTHER

Placebo Antibiotic and Placebo Valortim

Days 1-3 200mL IV Normal Saline for Placebo Antibiotic over 60 minutes. Day 4 200mL IV Normal Saline for Placebo Valortim over 60 minutes.

Trial Locations (1)

Quintiles Phase I Services, Overland Park